alexa Editor - Hardik Chandasana | University of Florida | 22729
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

33rd World Congress on Pharmacology

Barcelona, Spain
Share This Page

Hardik Chandasana

Hardik Chandasana
Hardik Chandasana
Dept. of Pharmacautics
College of Pharmacy,
University of Florida,
University of Florida


Hardik Chandasana obtained his B.Pharm from L. M. College of Pharmacy, Gujarat University, Ahmedabad, India and MS from Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER) Raebareli, India. Hardik Chandasana has received Ph.D in Drug Metabolism and Pharmacokinetics from CSIR-Central Drug Research Institute, Lucknow. Currently he is serving as Postdoctoral Research Associate at College of Pharmacy, University of Florida, and Gainesville, USA. Currently he is working in the area of PK/PD and Pharmacometrics. His research work has been published in the prominent journals in the area of pharmaceutical drug development such as Journal of Chromatography B, International Journal of Pharmaceutics, RSC Advances, Xenobiotics, Drug Testing and Analysis etc. He published more than 25 publications. He is also a reviewer for many of the journals. He has extensive experience on LC-MS/MS method development of small and large molecules, Pharmacokinetics (In-vitro and In-vivo) of NCEs and marketed molecules and PBPK model development.

Research Interest

PK/PD modeling, PBPK, Clinical Pharmacology, Drug Transporter, Nanotechnology based drug deliver, LC-MS/MS method development of small and large molecules, Pharmacokinetics (In-vitro and In-vivo) of NCEs and marketed molecules.